| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.1M | -1.3% |
| Cost of Revenue | $21.6M | -5.2% |
| Gross Profit | $6.5M | +14.5% |
| R&D Expense | $600K | -40.0% |
| SG&A Expense | $7.0M | -14.9% |
| Operating Income | -$518K | +79.9% |
| Pre-tax Income | -$1.4M | +54.8% |
| Income Tax | $440K | +185.5% |
| Net Income | -$1.8M | +27.7% |
| EPS (Basic) | -$0.05 | +28.6% |
| EPS (Diluted) | -$0.05 | +28.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.7M | +15.6% |
| Inventory | $7.9M | +13.4% |
| Current Assets | $15.1M | +8.9% |
| Total Assets | $24.3M | -6.5% |
| Current Liabilities | $11.2M | +6.2% |
| Long-term Debt | $2.6M | -14.7% |
| Total Liabilities | $14.8M | -1.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $673K | +171.3% |
| Capital Expenditures | $644K | -48.0% |
| Investing Cash Flow | -$644K | +30.8% |
| Financing Cash Flow | -$268K | -185.4% |
| Free Cash Flow | $28K | +101.3% |
| $9.5M |
| -13.5% |